News
- Author:
- Andrew D. Bowser
Publish date: January 24, 2019
Another cancer immunotherapy agent has positive results in ovarian cancer, which supports ongoing investigations of this checkpoint inhibitor in co...
News
- Author:
- Andrew D. Bowser
Publish date: January 23, 2019
This large, international, multicenter cohort study used a novel cluster analysis method.
News
- Author:
- Andrew D. Bowser
Publish date: January 22, 2019
Matched sibling donor hematopoietic stem cell transplants reduced an indicator of stroke risk, suggesting that the intervention may improve cerebro...
News
- Author:
- Andrew D. Bowser
Publish date: January 21, 2019
Transplant conferred a 70% reduction in overall death risk in patients with end-stage renal disease due to lupus nephritis.
News
- Author:
- Andrew D. Bowser
Publish date: January 18, 2019
No overall survival benefit was detected in this retrospective study, in contrast to a previous analysis.
News
- Author:
- Andrew D. Bowser
Publish date: January 17, 2019
Findings captured in Medicaid claims could help identify periods known to be tied to heightened suicide risk, such as right after discharge from in...
News
- Author:
- Andrew D. Bowser
Publish date: January 16, 2019
The findings suggest these new combinations may be more effective at clearing residual disease than rituximab-based therapy.
News
- Author:
- Andrew D. Bowser
Publish date: January 16, 2019
Individualized pharmacokinetic profiles developed using the web-based tools may have been a factor in improved adherence and bleeding rates.
News
- Author:
- Andrew D. Bowser
Publish date: January 14, 2019
Study may spur investigations into HDL particles.
News
- Author:
- Andrew D. Bowser
Publish date: January 14, 2019
Patients and physicians should be discussing the potential harms and downstream costs in shared decision-making visits.
News
- Author:
- Andrew D. Bowser
Publish date: January 13, 2019
The revised OSA threshold pointed to a increased risk for arrhythmias in the patients.
News
- Author:
- Andrew D. Bowser
Publish date: January 9, 2019
Degarelix, a gonadotropin-releasing hormone (GnRH) antagonist approved for prostate cancer, was more effective than the GnRH agonist triptorelin in...
News
- Author:
- Andrew D. Bowser
Publish date: January 8, 2019
Individuals going to rabies-endemic countries need a pretravel consultation with a travel health specialist regarding preexposure prophylaxis.
News
- Author:
- Andrew D. Bowser
Publish date: January 7, 2019
At least one actionable mutation was seen in 14% of women with breast and uterine cancer, compared with 9.3% of women with breast cancer only, in a...
News
- Author:
- Andrew D. Bowser
Publish date: January 7, 2019
Pancreatic and lung cancer patients had high rates of suicide in comparison to the general population, while breast and prostate cancer patients di...
